Sigma shares race to another record high. What's next?

What's next for the new-and-improved healthcare giant?

| More on:
Female pharmacist smiles with a digital tablet.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sigma Healthcare Ltd (ASX: SIG) shares have shot to another record high on Monday, bringing the new year's gains to 15% in the green already.

Shares in the healthcare giant hit a fresh high of $3.05 apiece this morning, surpassing their previous closing high of $3.00 last Friday.

Zooming out, the stock is up more than 216% in the past 12 months,

What's next for Sigma shares? Let's see what the experts think.

Why are Sigma shares climbing?

Taking a step back, Sigma shares have rallied this past year thanks to its 'back-door merger' with Chemist Warehouse.

After a series of setbacks, including scrutiny from the Australian Competition and Consumer Commission (ACCC), the regulator approved the merger late last year.

For reference, Chemist Warehouse first mentioned plans to merge with Sigma via the 'backdoor listing' last year. The deal was for Sigma to buy all of Chemist Warehouse's shares, effectively creating an indirect way for Chemist Warehouse to list its stock through the 'back door'. This is why it's known as a back-door listing.

Meanwhile, a scheme booklet outlining the deal's benefits suggested the combined group's FY24 operating profit could hit $605 million before accounting for any synergies.

In FY24, Sigma booked operating profit of $23 million, up 20% from the year prior. So the new entity is expected to grow operating profit by more than 27 times.

The merger's completion in November-December last year prompted feverish buying, with Sigma shares up 10% in the past month alone. Based on those estimates, it's not difficult to see why.

Is it too late to buy Sigma shares?

Investors are undoubtedly bullish on the newly formed entity's prospects, judging by how much Sigma shares have been bid up these past two months.

The proposed financials explain some of this in my opinion, especially given the jump in operating profit.

But brokers are optimistic, too. In December, according to The Australian, Morgans rated Sigma a buy, noting the potential value of the merged business.

Meanwhile, Barrenjoey analysts said the new group could see a doubling of earnings by FY28, as reported by The Australian Financial Review.

Not all are convinced, however. Alternative asset manager HMC Capital Ltd (ASX: HMC) trimmed its stake in Sigma the day the merger was confirmed.

The firm reduced its holding from more than 10.5% to just under 8.25%.

Meanwhile, the consensus of analyst estimates rates Sigma a sell, according to CommSec.

Safe to say, the opinion is split among the experts right now.

Foolish takeaway

Sigma shares are riding high on optimism from its Chemist Warehouse merger.

But brokers are split on where to next from here. Morgans and Barrenjoey are bullish, but others aren't convinced. Time will tell what happens to the newly formed healthcare group from here.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two lab workers fist pump each other.
Healthcare Shares

3 reasons to buy CSL shares today

Two investment experts expect a big turnaround for CSL shares in 2025.

Read more »

Business people discussing project on digital tablet.
Healthcare Shares

Down 4%, is the ResMed share price in the buy zone?

Do analysts think investors should be buying the dip? Let's see what they are saying.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Guess which ASX 100 share is sinking 8% because of Trump's tariffs

Donald Trump has dealt this company a big blow. What's happening?

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Up 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?

Mesoblast shares have surged more than 1,000% over the last 12 months.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Earnings Results

ResMed shares rise on strong Q2 result

Let's see how this sleep treatment company performed during the second quarter.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

$1,000 invested in Mesoblast shares at the start of 2024 is now worth…

Did this biotech company deliver the goods for investors? Let's see what a $1,000 investment would be worth.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Sigma share price drops after shareholders vote on Chemist Warehouse merger

The results are in.

Read more »

Man with his hand out the front, symbolising a trading halt.
Healthcare Shares

Halted: What's going on with Sigma shares today?

Sigma investors would be holding their breath right now.

Read more »